Literature DB >> 27380256

The use of a negative pressure wound management system in perineal wound closure after extralevator abdominoperineal excision (ELAPE) for low rectal cancer.

H Sumrien1, P Newman2, C Burt2, K McCarthy2, A Dixon2, A Pullyblank2, A Lyons2.   

Abstract

BACKGROUND: Perineal wound healing is a significant challenge after extralevator abdominoperineal excision (ELAPE) due to a high rate of wound breakdown. Negative pressure therapy has proven benefits in open wounds, and recently a negative pressure system has been developed for use on closed wounds at high risk of breakdown, such as apronectomy and hysterectomy. The aim of the present study was to determine whether negative pressure therapy applied to closed perineal wounds after ELAPE improved wound healing and compare outcomes to the published literature and outcomes from a historical cohort of patients who had undergone 'standard' abdominoperineal resection (APR) and primary closure of the perineal wounds.
METHODS: Prospective data on consecutive patients having ELAPE in the period from November 2012 to April 2015 were collected. The pelvic floor defect was reconstructed with biologic mesh. The adipose tissue layer was closed with vicryl sutures, a suction drain was left in the deep layer, the subcuticular layer and skin were closed, and the negative pressure system was applied. Any wound breakdown within the first 30 days postoperatively was recorded.
RESULTS: Of the 32 consecutive ELAPE patients whose perineal wounds were closed within 30 days with the use of the negative pressure system, there was 1 patient with major perineal wound breakdown and 2 patients with a 1 cm superficial wound defect, which needed no further treatment. In the remaining 29 (90 %) patients, the perineal wounds healed fully without complications. Twenty-five patients underwent standard APR in 2010-2011 with primary closure of their perineal wounds. Ten out of 25(40 %) of patients who had undergone standard APR and primary closure of perineal wounds had major wound complications (p = 0.01).
CONCLUSIONS: Our results suggest that after ELAPE the application of a negative pressure system to the perineal wound closed with biologic mesh may reduce perineal wound complications and may reduce the need for major perineal reconstruction.

Entities:  

Keywords:  ELAPE; Negative pressure therapy; Perineal wounds

Mesh:

Year:  2016        PMID: 27380256     DOI: 10.1007/s10151-016-1495-6

Source DB:  PubMed          Journal:  Tech Coloproctol        ISSN: 1123-6337            Impact factor:   3.781


  19 in total

Review 1.  Biological mesh in hernia repair, abdominal wall defects, and reconstruction and treatment of pelvic organ prolapse: a review of the clinical evidence.

Authors:  George Peppas; Ioannis D Gkegkes; Marinos C Makris; Matthew E Falagas
Journal:  Am Surg       Date:  2010-11       Impact factor: 0.688

2.  Primary perineal wound closure after preoperative radiotherapy and abdominoperineal resection has a high incidence of wound failure.

Authors:  Kelli M Bullard; Judith L Trudel; Nancy N Baxter; David A Rothenberger
Journal:  Dis Colon Rectum       Date:  2005-03       Impact factor: 4.585

Review 3.  Systematic review of molecular mechanism of action of negative-pressure wound therapy.

Authors:  G E Glass; G F Murphy; A Esmaeili; L-M Lai; J Nanchahal
Journal:  Br J Surg       Date:  2014-10-08       Impact factor: 6.939

4.  Extended abdominoperineal resection with gluteus maximus flap reconstruction of the pelvic floor for rectal cancer.

Authors:  T Holm; A Ljung; T Häggmark; G Jurell; J Lagergren
Journal:  Br J Surg       Date:  2007-02       Impact factor: 6.939

Review 5.  Extended abdominoperineal excision vs. standard abdominoperineal excision in rectal cancer--a systematic overview.

Authors:  Sigmar Stelzner; Carsta Koehler; Juliane Stelzer; Anja Sims; Helmut Witzigmann
Journal:  Int J Colorectal Dis       Date:  2011-05-21       Impact factor: 2.571

6.  Physical performance and quality of life after extended abdominoperineal excision of rectum and reconstruction of the pelvic floor with gluteus maximus flap.

Authors:  Markku M Haapamäki; Victoria Pihlgren; Owe Lundberg; Birger Sandzén; Jörgen Rutegård
Journal:  Dis Colon Rectum       Date:  2011-01       Impact factor: 4.585

7.  Perineal repair after extralevator abdominoperineal excision for low rectal cancer.

Authors:  Henrik Kidmose Christensen; Peter Nerstrøm; Troels Tei; Søren Laurberg
Journal:  Dis Colon Rectum       Date:  2011-06       Impact factor: 4.585

Review 8.  Reconstruction of the perineum following extralevator abdominoperineal excision for carcinoma of the lower rectum: a systematic review.

Authors:  J D Foster; S Pathak; N J Smart; G Branagan; R J Longman; M G Thomas; N Francis
Journal:  Colorectal Dis       Date:  2012-09       Impact factor: 3.788

Review 9.  Myocutaneous flap reconstruction of the pelvis after abdominoperineal excision.

Authors:  P J Nisar; H J Scott
Journal:  Colorectal Dis       Date:  2008-11-14       Impact factor: 3.788

10.  Incisional negative pressure wound therapy decreases the frequency of postoperative perineal surgical site infections: a cohort study.

Authors:  Sami A Chadi; Biniam Kidane; Karen Britto; Muriel Brackstone; Michael C Ott
Journal:  Dis Colon Rectum       Date:  2014-08       Impact factor: 4.585

View more
  13 in total

Review 1.  Meta-analysis of biological mesh reconstruction versus primary perineal closure after abdominoperineal excision of rectal cancer.

Authors:  Nasir Zaheer Ahmad; Muhammad Hasan Abbas; Noof Mohammed A B Al-Naimi; Amjad Parvaiz
Journal:  Int J Colorectal Dis       Date:  2021-01-03       Impact factor: 2.571

2.  Extended pelvic resection for rectal and anal canal tumors is a significant risk factor for perineal wound infection: a retrospective cohort study.

Authors:  Ken Imaizumi; Yuji Nishizawa; Koji Ikeda; Yuichiro Tsukada; Takeshi Sasaki; Masaaki Ito
Journal:  Surg Today       Date:  2018-06-01       Impact factor: 2.549

3.  Incisional Negative-Pressure Wound Therapy for Perineal Wounds After Abdominoperineal Resection for Rectal Cancer, a Pilot Study.

Authors:  Maxime J M van der Valk; Eelco J R de Graaf; Pascal G Doornebosch; Maarten Vermaas
Journal:  Adv Wound Care (New Rochelle)       Date:  2017-12-01       Impact factor: 4.730

4.  Negative-Pressure Wound Therapy to Reduce Wound Complications after Abdominoperineal Resection.

Authors:  Rebecca Gologorsky; Shruti Arora; Anahita Dua
Journal:  Perm J       Date:  2020-02-07

5.  The application of incisional negative pressure wound therapy for perineal wounds: A systematic review.

Authors:  Caitlin Cahill; Amanda Fowler; Lara J Williams
Journal:  Int Wound J       Date:  2018-06-04       Impact factor: 3.315

6.  Transvaginal Small Bowel Evisceration following Abdominoperineal Resection.

Authors:  Enver Kunduz; Huseyin Bektasoglu; Samet Yigman; Huseyin Akbulut
Journal:  Case Rep Surg       Date:  2018-02-15

Review 7.  Extralevator abdominoperineal excision for advanced low rectal cancer: Where to go.

Authors:  Yu Tao; Jia-Gang Han; Zhen-Jun Wang
Journal:  World J Gastroenterol       Date:  2020-06-14       Impact factor: 5.742

8.  Application of modified primary closure of the pelvic floor in laparoscopic extralevator abdominal perineal excision for low rectal cancer.

Authors:  Yan-Lei Wang; Xiang Zhang; Jia-Jia Mao; Wen-Qiang Zhang; Hao Dong; Fan-Pei Zhang; Shuo-Hui Dong; Wen-Jie Zhang; Yong Dai
Journal:  World J Gastroenterol       Date:  2018-08-14       Impact factor: 5.742

9.  Case series of in situ pelvic floor reconstruction combining levator ani suture and negative pressure wound therapy for abdominoperineal resection.

Authors:  Eisaku Ito; Masashi Yoshida; Hironori Ohdaira; Masaki Kitajima; Yutaka Suzuki
Journal:  Ann Med Surg (Lond)       Date:  2019-05-31

10.  Incisional negative pressure wound therapy to reduce perineal wound infection after abdominoperineal resection.

Authors:  Tomoaki Kaneko; Kimihiko Funahashi; Mitstunori Ushigome; Satoru Kagami; Mayu Goto; Takamaru Koda; Akiharu Kurihara
Journal:  Int Wound J       Date:  2020-11-25       Impact factor: 3.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.